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Introduction 
In the last several years a variety of new observations 
have appeared which bear on the in vivo complexing 
of eukaryotic messenger RNA (mRNA) sequences 
with proteins in the nucleus and cytoplasm. Our 
purpose in this article is to review only the recent 
experimental evidence relevant o the problem of the 
proteins complexed with heterogeneous nuclear RNA 
(hnRNA). 
This essay is divided into four sections. Part I 
describes the methods currently used to isolate 
hnRNP particles and the problems associated with 
it. Part 2 deals with the RNA portion of the hnRNP 
particles, while part 3 is devoted to the proteins 
found to be associated with hnRNA. In the final 
section we review current knowledge regarding the 
function and structure of these particles. 
1. Isolation of hnRNP particles 
To obtain pure hnRNP particles it is first necessary 
to start with the isolation of a nuclei preparation 
which is not contaminated with cytoplasmic material. 
This criterion can be met, for example, by centrifuga- 
tion of the cell lysate through eavy sucrose solutions 
(1) which may be followed by successive washings of 
the nuclei with buffer solutions containing low con- 
centrations of non-ionic detergents (2, 3, 4). 
Two procedures for the isolation of crude hnRNP 
particles are now widely used. In the first procedure, 
originally described by Samarina et al. (5), rat liver 
nuclei were first extracted with a neutral buffer and 
subsequently extracted several times with the same 
buffer at pH 8.0 in the presence of a ribonuclease 
inhibitor. The combined pH:8.0 extracts contained 
hnRNP particles with sedimentation coefficients in 
sucrose gradients ranging from 30 - 200 S and CsC1 
densities of 1.39 - 1.40 g/cm 3 . The presence of the 
ribonuclease inhibitor during the extraction was 
essential since only particles of about 30 S were 
found in the absence of the inhibitor. This extrac- 
tion method has been used and modified by several 
workers (2, 6-14). An interesting modification was 
found by Ishikawa et al. (7) who were able to extract 
hnRNP particles from rat liver nuclei at neutral pH 
by adding ATP to the extraction buffer. Since EDTA 
and pyrophosphate could be substituted for ATP, it 
seems that it is the chelating capacity of the ATP that 
is involved in the release of hnRNP from chromatin 
(3). 
A second method for the isolation of hnRNP 
particles was described by Parsons and McCarty 
(15, 16). Washed rat liver nuclei were sonicated in 
a buffered 0.35 M sucrose solution (16) and after 
removal of membranes and nucleoli the hnRNP 
particles were purified via sucrose gradient centri- 
fugation. The hnRNP particles present in the nuclear 
lysate obtained either by sonication or extraction 
with buffer are usually purified by sucrose gradient 
centrifugation although in some cases affinity chro- 
matography has been used (8, 17-19). 
The sonication method has been used in the 
isolation of hnRNP particles from a wide variety of 
normal and transformed cells (3, 8, 9, 13, 18, 20-25), 
in contrast o the extraction method which seems 
less widely applicable. For KB cells and HeLa cells, 
for instance, a higher temperature was needed (2,,8, 
10) and for ascites tumor cells a higher pH was more 
favourable (11). It was further observed that with 
some fast growing cell types (e.g. rat hepatoma cells) 
only the sonication method yielded significant 
amounts of hnRNP particles (8, 21, 23). Other 
advantages of the sonication method over the extrac- 
tion method are its rapidity and the fact that it can 
be used at low temperatures thus diminishing the 
possibility of degradation of hnRNP. 
The hnRNP particles (40-250 S) found after 
sonication had a similar CsC1 density as the particle 
population isolated by the Samarina method (5). 
Degradation of these intact hnRNP structures by 
endogenous or added ribonuclease r leased monomer 
RNP particles of about 30 S. These 30 S subparticles 
(30 - 40 S according to some authors (2, 24)) have an 
RNA to protein ratio of about 1:4 to 1:5 as indicated 
by their buoyant density of 1.40 g/cm 3 in CsC1 (5, 8, 
26, 27). Samafina nd coworkers (5, 26, 28) proposed 
that these 30 S subparticles were composed of a 
residual-stretch of hnRNA attached to a globular 
protein particle, called an informofer (5, 26). An 
informofer was thought o be a complex of a number 
of (identical) proteins with a subunit molecular 
weight of about 40,000 (26, 29). 
The 30 S RNP subparticles show a rather homo- 
geneous peak in sucrose gradients (2, 5, 26) and 
electronmicroscopic observations revealed them to be 
rather homogeneous particles of about 200 - 300 A in 
diameter (26, 30-32). Treatment of brain nuclear 
hnRNP particles with increasing concentrations of
ribonuclease, however, suggested the existence of 
different classes of monomer particles (33) with 
different protein composition (24)-. Several reports 
demonstrate hat some of the 30 S RNP proteins are 
more tightly (mostly interpreted as more specifically) 
bound than others (2, 24), a characteristic that can 
easily lead to a heterogeneous population of 30 S 
subparticles. It would be worthwhile trying other 
techniques (for example metrizamide gradients (9, 
25), high resolution CsC1 gradients (34, 35) or poly- 
acrylamide-agarose composite gel electrophoresis 
(36)) in order to demonstrate the microheterogeneity 
of these particles. 
2. The RNA in hnRNA and hnRNP 
This chapter will be limited to summarizing the 
known facts about the characteristics of hnRNA and 
its relation to cytoplasmic mRNA. Several excellent 
reviews are available which consider the evidence 
underlying these conclusions (37-40). 
a. The presence of mRNA sequences 
The rapidly synthesized hnRNA is found complexed 
with proteins (5, 6, 8, 41), and the hnRNP parti- 
cles isolated as described in the previous section 
contain the bulk of the hnRNA molecules (26, 28, 
42). Hybridization experiments between RNA or 
DNA complementary to mRNA and purified hnRNA 
(15, 38, 40, 43-47) indicate that mRNA sequences 
are found in hnRNA molecules. Further evidence 
on this point can be found in the successful transla- 
tion of hnRNA in oocytes and cell-free systems (3, 
48-50), from kinetic studies with and without tran- 
scriptional inhibitors (8, 38) and from the similarity 
in the types of posttranscriptional modification 
characteristic of hnRNA and mRNA (38). Although 
all these methods have their specific draw-backs 
(especially concerning the purity of the mRNA and 
hnRNA preparations used) all these experiments 
taken together provide strong evidence for the 
occurrence of mRNA sequences in hnRNA. In fact, 
recent work with carefully purified RNA prepara- 
tions from globin synthesizing cells (mouse spleen, 
fetal mouse liver and mouse Friend cells) led to the 
identification of the immediate precursor of 9 S 
globin mRNA as a 15 S component (51, 52). Fur- 
thermore, Bastos and Aviv have shown that this 
15 S component is a nuclear cleavage product of a 
still larger precursor of about 27 S (53). 
Recent findings also suggest hat probably all 
poly(A)-containing mRNA sequences found in the 
cytoplasm are present in hnRNPoRNA (and notably 
in the informofer-like 30 S RNP particles) while on 
the other hand only a small part of the hnRNP- 
RNA sequences can be detected in the cytoplasm 
(42, 44). This means that the greater part of the 
hnRNA molecules turns over within the nucleus, 
as has been suggested earlier by several workers on 
basis of kinetic data (54-57). 
b. The presence of poly(A) and oligo(A) sequences 
The 3'poly(A) segments characteristic of most 
cytoplasmic mRNAs have been shown to be pre- 
sent in hnRNA and hnRNP complexes (11, 17, 18, 
39, 43, 58). The poly(A) is added posttranscriptio- 
nally by a terminal addition enzyme (see for exam- 
ple 59). It has been found by several authors that 
the poly(A), like the rest of hnRNA, is (partly) 
covered with protein and is released as a 10 - 16 S 
poly(A)-protein complex after ribonuclease degra- 
dation of hnRNP complexes (11,58, 60, 61). 
In addition to the long postt~anscriptionally dded 
poly(A) segments (150-200 nucleotides long)there 
are also short transcribed AMP-rich sequences present 
in hnRNA and hnRNP (37, 62, 63). These oligo(A) 
sequences (about 30 nucleotides long) seem to be 
primarily present in those hnRNA molecules that 
do not contain the long poly(A) sequences (37, 62). 
A considerable fraction of these oligo(A) stretches 
was found in 30 S hnRNP particles (42, 63). It was 
proposed that they might function as primers for 
polyadenylation (37, 63). 
c. The presence of oligo(U) sequences 
The presence of short oligo(U) sequences of about 
30 nucleotides in hnRNA was first demonstrated by
Molloy and coworkers (64) and shown not to be 
localized near the 3'terminus (65) although this point 
is still in dispute (22). There are indications that these 
sequences are present only in polyadenylated hnRNA 
and as such may contribute to the secondary struc- 
ture of hnRNA (66). 
Recently, oligo(U) sequences have been shown 
to be present in hnRNP complexes i olated either by 
sonication or by extraction at pH x 9..0. In both cases 
(22, 61) the oligo(U) sequences were found in a 
ribonuclease resistant duplex with the poly(A) of 
the hnRNP particles after phenol-chloroform extrac- 
tion of the hnRNA but there is some disagreement as 
to whether the oligo(U) sequences could become 
associated artefactually with the poly(A) of hnRNP 
during isolation. Quinlan and coworkers (61)showed 
that hnRNP-poly(A) from Taper hepatoma scites 
cells could bind added poly(U) during RNA extrac- 
tion and, conversely, that added poly(A) increased 
the yield of ribonuclease resistant oligo(U)-poly(A) 
duplexes. Although these results do not exclude the 
presence of oligo(U)-poly(A) duplexes in hnRNP, 
they do show that artefactual formation of such 
duplexes during preparative procedures i possible. 
Kish and Pederson (22) on the other hand con- 
cluded from their experiments with HeLa cells that 
the oligo(U)-poly(A) duplexes were genuine. They 
isolated these duplexes in the presence of an excess 
of oligo(dT) which was assumed (but not proven) 
to block the free poly(A) sequences of hnRNP 
completely from artefactual ssociation with oligo(U) 
sequences present in the nuclear lysate. 
d. The presence of (sn)RNA species 
Recent reports from Sekeris and coworkers (12, 
13, 67) indicate that in addition to the rapidly syn- 
thesized hnRNA molecules smaller, metabolically 
more stable, nuclear RNA species are present in 
undegraded rat liver hnRNP particles. These RNA 
molecules could be identical with some of the stable 
nuclear (sn)RNA species isolated by various authors 
from several types of cells (68, 69) and which have 
been shown to be present in RNP structures (70). 
3. The proteins in hnRNP particles 
There is an abundance of material concerning the 
protein composition of hnRNP complexes (2, 4, 8, 9, 
13, 14, 17-21, 24, 25, 71-74). Since large discrepan- 
cies are found in the reports on the number and 
molecular weight distribution of the proteins asso- 
ciated with the hnRNA, however, it seems useful to 
first discuss some of the problems involved in this 
matter. 
a. Cytoplasmic contamination (see section 2) 
should be kept as remote as possible. Not all workers 
purify the nuclei in the same way or to the same ex- 
tent and this can easily introduce discrepancies in
the protein patterns found. 
b. Differences in the protein composition of 
hnRNP particles may be the direct result of differ- 
ences in the isolation procedures. For example, the 
protein composition of 30S hnRNP particles in most 
cases is quite simple in contrast o that of intact 
hnRNP (see below). Uncontrolled endogenous ribo- 
nuclease activity during the isolation procedure may 
convert (specifically or non-specifically) hnRNP 
particles into 30S RNP particles and introduce un- 
known losses of hnRNP protein. Also, the uncon- 
trolled presence of nuclear proteases can be a major 
problem in these experiments. Furthermore, it 
should be realized that most results were obtained 
with RNP particles purified by sucrose gradient 
centrifugation only, under conditions that do not 
effectively remove adsorbed proteins. For example, 
high salt washes are often omitted because hnRNP 
particles tend to disaggregate much easier in high salt 
solutions than cytoplasmic mRNP particles (2, 4, 8, 
17, 71, 75). On the other hand, this property can be 
used advantageously as a measure of the specificity 
of the protein-hnRNA interaction as has been shown 
by Beyer et al. (2). 
c. Some of the proteins associated with hnRNA 
may be species-specific. This possibility has been 
substantiated by the results obtained by Pederson 
(8, 17) and recently Beyer et al. (2). Other workers 
have found small quantitative changes in the protein 
composition of hnRNP particles which are thought o 
be induced by carcinogenic reagents (21,76). 
The protein composition of intact hnRNP particles 
is very complex as can be concluded from the analysis 
of hnRNP particles isolated by sonication (4, 9, 21, 
24, 25), extraction or lysis in the presence of ribonu- 
clease inhibitor (14, 27, 71,73) or affinity chromato- 
graphy (8, 17-19). Most workers find a series of 
proteins ranging in molecular weight from 22,000 to 
150,000 with some predominant components around 
40,000 (4, 8, 14, 19-21, 24, 73). Similar results were 
obtained when the hnRNP particles were subjected to 
a 0.5 M KC1 wash (4, 8, 19, 71), a treatment that is 
known to remove less tightly bound proteins from 
RNP particles. 
The dominating protein bands of about 40,000 
daltons present in undegraded hnRNP complexes are 
most probably identical with the 40,000 dalton pro- 
teins that are the structural components of the 
informofer-like 30S particles (23, 29). The use of 
high resolution polyacrylamide g l systems has shown 
that purified, high-salt-washed 30S particles from a 
variety of cultured cells contain at least wo proteins 
having almost identical molecular weights around 
40,000 daltons (2, 11, 60). 
Recent reports have characterized some of these 
proteins. The major proteins of the 30S particles in 
HeLa cells (77), mouse ascites cells (60) and rat brain 
(24, 71) are subject o posttranslational phosphoryla- 
tion and it has been shown that these phosphorylated 
proteins are more tightly bound to hnRNA sequences 
than the non-phosphorylated ones (71). 
Some amino acid compositions of structural pro- 
teins in 30S subparticles have been published (2, 29). 
In rat liver the principal component of informofers i
a more or less neutral protein (29~), while the most 
abundant structural proteins in 30S subparticles from 
HeLa cells are basic polypeptides with a high glycine 
content and a modified arginine residue (2). Such an 
arginine residue with two methylgroups added to the 
guanidino group (N G , N G , dimethylarginine) has also 
been found in rat liver nuclear RNP (78). This is an 
interesting ffmding because the guanidino group of 
arginine may be involved in the interaction between 
proteins and nucleic acids (79, 80). 
The interesting question whether some hnRNP 
proteins are identical with proteins present in cyto- 
plasmic mRNP is still unresolved. Lukanidin et al. 
(81) used an immunological pproach and concluded 
from their experiments hat the 40,000 dalton pro- 
tein present in rat liver informofers was absent from 
polysomal mRNP. Most workers, comparing the 
electrophoretic mobilities of hnRNP proteins and 
polysomal mRNP proteins, agree that the predomi- 
nant proteins associated with polysomal mRNA are 
only minor proteins, if present at all, in the nuclear 
particles (4, 8, 19, 82, 83). 
This also holds for the poly(A) associated 76,000 
dalton protein which is one of the major proteins of 
polysomal mRNPs (84-86) but appears as only a very 
minor component of the HeLa cell hnRNP particles 
after oligo(dT)-cellulose purification and .which in 
fact is not readily observed at all in electropherograms 
of total hnRNP protein (18, 19). It was found, how- 
ever, as a major component after isolation of the 
nuclear poly(A)-protein complexes from HeLa cells 
(18, 19), and in another system (the cellular slime 
mold Dictyostelium discoideum) a 73,000 dalton 
component was found to be associated with the 
poly(A) of hnRNP particles (17). From mouse ascites 
nuclei (Taper liver tumor) two classes of poly(A)- 
protein complexes were isolated (t i, 60). One frac- 
tion, sedimenting at 17S, contained at least six pro- 
reins with molecular weights between 17,000 and 
30,000 daltons. The second fraction (15S) had a 
predominant protein with a molecular weight of 
80,000 daltons. Unfortunately, the possibility of 
cytoplasmic ontamination was not rigorously ex- 
cluded in either case. This is important, since the use 
of affinity chromatography (17-19) may (preferen- 
tially) co-purify cytoplasmic poly(A) containing 
mRNP. 
4. Structure and function of hnRNP 
A simple model for the structure of hnRNP com- 
plexes was the informofer model proposed by Sama- 
rina et al. (5, 28, 58). In this model the hnRNP par- 
ticles were visualized as a number of globular particles 
composed of one main protein (40,000 daltons) 
attached to a heterogeneous population of RNA 
strands which had poly(A)-segments complexed with 
proteins on their ends (58). Although proteins cer- 
tainly play an important role in the maintenance of
hnRNP structure, more recent work points to a 
model in which the hnRNA is an integral part of 
the globular 30S particles described by Samarina. 
On the basis of sequential release of proteins from 
hnRNP particles by salt or ribonuclease treatments, 
a so called "folded ribonucleoprotein strand" struc- 
ture was proposed by Stevenin and Jacob (24, 75, 
87) and supported by others (12, 42). Several groups 
have shown that complex-formation f protein with 
hnRNA occurs during transcription (25, 41, 88-90) 
and electronmicroscopic observations have shown 
that long RNA molecules interact with protein 
during transcription to form repeating 200-240 A 
particles with apparently equal spacing and size (3 I, 
91). As a result of this association with protein the 
RNA is foreshortened considerably (30) and it seems 
that in this way the cell can handle (by condensing) 
and protect (by covering it with protein) long, unsta- 
ble lengths of RNA while still leaving them available 
for further enzymatic modification..An identical 
situation appears in nucleosomes, where the DNA is 
considerably condensed but obviously still accessible, 
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Fig. 1. Schematic drawing of a possible model of hnRNP structure. 
stabilizing of the hnRNP network may be obtained 
by binding to nuclear structures as was suggested by 
Faiferman and Pogo (93). 
A possible model of hnRNP structure is depicted 
in figure 1. It shows the 30S subparticles containing 
the majority of the hnRNA sequences (8, 28, 60) 
in a condensed form bound to a simple set of poly- 
peptides. The ribonuclease sensitive sites of the 
hnRNA (between the 30S subparticles) are (partly) 
covered with a completely distinct and heterogeneous 
group of  proteins. The poly(A)-segment is also partly 
protected by specific proteins. Other - more or less 
similar - models of  hnRNP structure have been 
published by Sekeris and Niessing (12), Kinniburgh et 
al. (42) and Samarina et al. (26, 58). 
In addition to a group of proteins involved in pro- 
tection or stabilization, hnRNP may also contain 
accessory proteins involved in the processing of  
hnRNA (25). Niessing and Sekeris (72) described 
the presence of  a nuclease activity in 30S hnRNP 
particles which in vivo might be involved in the 
cleavage of hnRNA. The same authors also described 
the presence of  two poly(A) polymerase activities in 
the RNP particles from rat liver nuclei and the occur- 
rence of  a r ibohomopolymer synthetase which can 
polymerize ATP, GTP, UTP and CTP to the corre- 
sponding ribohomopolymers (94). 
In examining the current literature it is apparent 
that the function of the proteins associated with 
hnRNA is still unexplained. It is tempting to specu- 
late that they are involved in such poorly under- 
stood processes as the conversion of nuclear precur- 
sors to functional cytoplasmic mRNA and the trans- 
port of processed mRNA sequences into the cyto- 
plasm. 
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